| Financial Year |
March 31 2023 |
| Monetary Funds |
122,277,259.85 |
| Held-for-trading Financial Assets |
737,929,531.35 |
| Notes Receivable |
-- |
| Accounts Receivable |
162,087,342.01 |
| Advances to Suppliers |
16,810,832.33 |
| Other Receivables |
78,671,766.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
137,255,794.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,196,129.95 |
| Total Current Assets |
1,283,696,262.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,679,042.09 |
| Fixed Assetes |
23,338,687.26 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,004,652.41 |
| R&D expenses |
-- |
| Goodwill |
22,905,462.09 |
| Long-Term Deferred and Prepaid Expenses |
7,338,631.32 |
| Deferred Income Tax Assets |
1,025,700.33 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
460,653,722.86 |
| Total Assets |
1,744,349,985.77 |
| Short-Term Loans |
1,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
65,122,633.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
171,247,067.97 |
| Taxes Payable |
8,643,199.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
123,856,764.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
10,183,165.77 |
| Sub-Total of Current Liabilities |
495,952,256.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
500,000.00 |
| Deferred Income Tax Liabilities |
61,637,762.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,721,546.57 |
| Total Liabilities |
560,673,802.60 |
| Paid-In Capital(Or Share Stock) |
480,158,629.00 |
| Capital Surplus |
369,415,594.57 |
| Surplus Reserve |
124,337,435.75 |
| LESS:Treasury Stock |
83,561,807.20 |
| Undistributed Profits |
182,590,934.49 |
| Minority Stockholder's Interest |
110,735,396.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,072,940,786.61 |
| Owner's Equity（Stockholder's Equity） |
1,183,676,183.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,744,349,985.77 |
